Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Apr 16, 2020 Theratechnologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) Apr 14, 2020 Theratechnologies Announces Financial Results For The First Quarter of 2020 Mar 31, 2020 Theratechnologies Provides Business Update Related To Current Covid-19 Situation Mar 11, 2020 Visceral Fat Is A Predictor Of Liver Fibrosis And Fibrosis Progression In People Living With HIV Mar 02, 2020 Change To Theratechnologies Management Feb 25, 2020 Theratechnologies Announces Financial Results For Fiscal Year 2019 Feb 18, 2020 Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019 Feb 04, 2020 Theratechnologies signs agreements with Massachusetts General Hospital and Dr. Steven Grinspoon Dec 19, 2019 Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020 Dec 13, 2019 Theratechnologies’ Oncology Platform Improves Efficacy and Tolerability of Docetaxel In Vivo and In Vitro First page « Previous page ‹ … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page › Last page » Displaying 181 - 190 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Mar 11, 2020 Visceral Fat Is A Predictor Of Liver Fibrosis And Fibrosis Progression In People Living With HIV
Feb 04, 2020 Theratechnologies signs agreements with Massachusetts General Hospital and Dr. Steven Grinspoon
Dec 19, 2019 Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020
Dec 13, 2019 Theratechnologies’ Oncology Platform Improves Efficacy and Tolerability of Docetaxel In Vivo and In Vitro
